Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MS&D patents new class of selective human 5-HT2A receptor antagonists

Feb. 21, 2000

Selective 5-HT1D receptor ligands discovered by Allelix (NPS Allelix)

Feb. 21, 2000

Boston Life Sciences describes positive preclinical findings with new antiparkinsonian

Feb. 21, 2000

Evidence obtained by Gliatech supporting the role of inflammation in AD

Feb. 21, 2000

Melatonin aids in benzodiazepine discontinuation

Feb. 18, 2000

Ganaxolone produces only modest beneficial effects in cerebral hematoma model

Feb. 17, 2000

Endonuclease activity as a potential therapeutic target for preventing neuronal apoptosis

Feb. 16, 2000

Active Biotech reports on quinolines particularly useful in MS

Feb. 16, 2000

Transmucosal clemastine under study at Nastech for motion sickness

Feb. 16, 2000

Agents with nanomolar affinity for the MDR binding site jointly discovered by Japanese labs

Feb. 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...